title: Clinical inquiry: do complementary agents lower HbA1c when used with standard type 2 diabetes therapy?
authors: New Hanover Regional Medical Center Residency in Family Medicine, Wilmington, NC, USA.
authors: Monique M
authors: MM
authors: Moona
authors: Richard
authors: R
authors: Smits
authors: Joseph
authors: J
authors: Kertesz
authors: Albert
authors: A
authors: Meyer
authors: Leslie
authors: L
authors: Mackler
mesh_terms: D002857:Chromium / Q000627:therapeutic use; D002935:Cinnamomum zeylanicum; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000628:therapy*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D027723:Ipomoea batatas; D020944:Silybum marianum; D008517:Phytotherapy; D016032:Randomized Controlled Trials as Topic; D012450:Safflower Oil; D014131:Trace Elements / Q000627:therapeutic use; D029910:Trigonella
chemical_list: D002857:Chromium; D006442:Glycated Hemoglobin; D012450:Safflower Oil; D014131:Trace Elements; C517652:hemoglobin A1c protein, human